USClinicalTrials.govClinical trial
A Study of a Side Effects and Resource Navigation Program for People With Cancer
Not applicableRecruitingJul 31, 2026
Cancer types
Breast Cancer
All subtypes, incl. HR+, HER2+, TNBC. 62 official records currently indexed across three regions.
Trial records retrieved live from the ClinicalTrials.gov public API.
Showing 62 of 62
Highlight terms:
USClinicalTrials.govClinical trial
A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer
Phase 1RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Adaptive Symptom Self-Management Immunotherapy Study
Not applicableActive, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Phase 3RecruitingJul 31, 2026
OTHERClinicalTrials.govClinical trial
Analgesic Efficacy of Combined PECS II and PIP Block Versus Thoracic Paravertebral Block Post-Mastectomy
Not applicableRecruitingJul 31, 2026
OTHERClinicalTrials.govClinical trial
Antibody-based PET Imaging and Treatment Response in Breast Cancer Treated With an Antibody-drug Conjugate.
Phase 2Not yet recruitingJul 31, 2026
EUClinicalTrials.govClinical trial
Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Breast Cancer, Reasoning, and Activity Intervention
Not applicableRecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
Phase 2Active, not recruitingJul 31, 2026
EUClinicalTrials.govClinical trial
Clinical Trial Evaluating the Efficacy and Implementation of an Early Adapted Physical Activity to Prevent and Manage Aromatase Inhibitor-induced Musculoskeletal Pain in Breast Cancer (APIS)
Not applicableRecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Collection of CSF Samples From Participants With Metastatic Triple Negative Breast Cancer (TNBC) and HER2+ Breast Cancer With no Prior History Nor Active Radiographically Detectable Brain Metastases
Not yet recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
Not applicableRecruitingJul 31, 2026
EUClinicalTrials.govClinical trial
Effects of Negative Pressure Wound Bandaging After Mastectomy
Not applicableRecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Phase 2RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic
Phase 3Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
EXERT-BC Cardio: Cardio or Conditioning Training With Breast Cancer
Not applicableNot yet recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trial
GB268 Monotherapy or Combination Therapy for Locally Advanced/Metastatic Breast Cancer (Phase Ib/Ⅱ)
Phase 1/2Not yet recruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trial
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Phase 3Active, not recruitingJul 31, 2026
EUClinicalTrials.govClinical trial
Implementing Polygenic Risk Scores for Breast Cancer Prevention: a Feasibility Study
Not applicableRecruitingJul 31, 2026
EUClinicalTrials.govClinical trial
Investigation of Tumour Spectrum of Germline Mutations in Breast and Ovarian Cancer Genes.
Not applicableActive, not recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trial
Long Term Cohort Study of Adding Ovarian Function Suppression to Tamoxifen in Young Women
Not yet recruitingJul 31, 2026
USClinicalTrials.govClinical trial
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
Not applicableRecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Natural History Study of Early Life Exposures in Agriculture (ELEA)
Enrolling by invitationJul 31, 2026
EUClinicalTrials.govClinical trial
Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent Breast Cancer Using Genomic Tests
Phase 3RecruitingJul 31, 2026
OTHERClinicalTrials.govClinical trial
Paclitaxel Oral Solution in HER2-Positive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study
Phase 1/2Not yet recruitingJul 31, 2026
OTHERClinicalTrials.govClinical trial
Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study
Phase 1/2Not yet recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women
Not applicableActive, not recruitingJul 31, 2026
EUClinicalTrials.govClinical trial
Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy
Phase 3Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Active, not recruitingJul 31, 2026
USEUOTHERClinicalTrials.govClinical trial
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
Phase 3Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Phase 2Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Phase 2RecruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Phase 3Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing Olaparib Either Alone or in Combination With Atezolizumab in BRCA Mutant Non-HER2-positive Breast Cancer
Phase 2Active, not recruitingJul 31, 2026
USOTHERClinicalTrials.govClinical trial
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
Phase 1Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer
Phase 1Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast Cancer
Phase 1/2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Addition of Radium Therapy (Radium-223 Dichloride) to the Usual Chemotherapy Treatment (Paclitaxel) for Advanced Breast Cancer That Has Spread to the Bones
Phase 2Active, not recruitingJul 31, 2026
USClinicalTrials.govClinical trial
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
Phase 1RecruitingJul 31, 2026
USClinicalTrials.govClinical trial
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Phase 1Active, not recruitingJul 31, 2026
CNCDERegulatory
CDE 临床试验默示许可 — clinical trial implied licence notices
Continuously updated
CNCDERegulatory
CDE 优先审评公示 — priority review listings
Continuously updated
CNCDERegulatory
CDE 受理品种信息 — applications accepted for review
Continuously updated
CNCDEGuideline
CDE 指导原则 — published technical guidance documents
Continuously updated
CNCDERegulatory
CDE 突破性治疗公示 — breakthrough therapy designation notices
Continuously updated
CNCDERegulatory
CDE 附条件批准品种 — conditionally approved products list
Continuously updated
CNChiCTRRegistry
ChiCTR — Chinese Clinical Trial Registry, public search
Continuously updated
EUCTISRegistry
CTIS public register — search clinical trials authorised in the EU/EEA
Continuously updated
EUEMARegulatory
EMA — CHMP meeting highlights and opinions on new medicines
Continuously updated
EUEMARegulatory
EMA — medicines for human use currently under evaluation (monthly CHMP list)
Continuously updated
EUEMARegulatory
EMA — searchable database of authorised medicines in the EU
Continuously updated
EUESMOGuideline
ESMO Clinical Practice Guidelines — breast cancer
Continuously updated
EUESMOGuideline
ESMO Clinical Practice Guidelines — public index by tumour type
Continuously updated
EUESMOGuideline
ESMO Clinical Practice Guidelines — supportive and palliative care section
Continuously updated
USFDARegulatory
FDA — expanded access (compassionate use) information for patients
Continuously updated
USFDARegulatory
FDA — oncology (cancer) / hematologic malignancies approval notifications
Continuously updated
USFDARegulatory
FDA — ongoing accelerated approvals for oncology indications
Continuously updated
USNCCNGuideline
NCCN Guidelines — palliative care category listing
Continuously updated
USNCCNGuideline
NCCN Guidelines — public index by cancer type (free registration)
Continuously updated
USNCCNGuideline
NCCN Guidelines for Patients — plain-language versions
Continuously updated
CNNMPARegulatory
NMPA 药品 — national drug approval announcements
Continuously updated
CNCDERegistry
药物临床试验登记与信息公示平台 — national registry of drug trials conducted in China
Continuously updated
This site does not provide medical advice
TrialBeacon only aggregates links to publicly available official information. It does not recommend, rank or evaluate any treatment, trial or medicine, and nothing here implies suitability for any individual. Please discuss anything you find with your treating doctor, and always rely on the original official page — records change over time. Full disclaimer.